SuperworthGE HealthCare Technologies price to book ratio GEHC
Market value divided by the book value of the company's net assets, since 2023.
- Today, Oct 23, 2026
- 2.9×
- 3-year median
- 4.4×
- Against its 3-year history
- 11th
- percentile: 0 is its lowest day, 100 its highest
- 3-year range
- 2.6× to 6.0×
- Peer median
- 3.4×
GE HealthCare Technologies' price to book ratio is 2.9× as of Oct 23, 2026.
That is below its 3-year median of 4.4×, lower than on 89% of days in the last 3 years.
Over that time it ranged from 2.6× in Jul 2026 to 6.0× in Mar 2024.
The median for 9 medical device stocks of a similar size is 3.4×.
Price to book ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 2.9× | 2.6× | 4.0× |
| 2025 | 3.8× | 3.3× | 5.0× |
| 2024 | 4.4× | 4.3× | 6.0× |
| 2023 | 4.9× | 4.0× | 5.6× |
Against its peers
Companies in Medical - Devices nearest GE HealthCare Technologies' size, closest first, today.
| Company | Price to book ratio |
|---|---|
| GEHCGE HealthCare Technologies | 2.9× |
| DXCMDexCom | 11.2× |
| EWEdwards Lifesciences | 4.8× |
| ZBHZimmer Biomet | 1.5× |
| BSXBoston Scientific | 2.7× |
| SYKStryker | 4.9× |
| MDTMedtronic | 2.4× |
| ABTAbbott Laboratories | 3.5× |
| LIVNLivaNova | 3.4× |
| ITGRInteger | 2.5× |
| Peer median | 3.4× |
What the price to book ratio tells you
Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.
Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.
More on GE HealthCare Technologies
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.